AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Q1 2008 Human Genome Sciences Earnings Conference Call - Final.

Fair Disclosure Wire

| May 05, 2008 | COPYRIGHT 2008 CQ Transcriptions. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Original Source: FD (FAIR DISCLOSURE) WIRE

OPERATOR: Welcome to the Human Genome Sciences first quarter 2008 financial results conference call. (OPERATOR INSTRUCTIONS) It's my pleasure to turn the call over to Thomas Watkins, President and Chief Executive Officer of Human Genome Sciences. Please go ahead.

THOMAS WATKINS, CEO, PRESIDENT, HUMAN GENOME SCIENCES INC.: Thank you, operator and good afternoon, everyone. Thank you all for joining us. Those of you who have not seen the press release that we issued a short time ago will find it posted on our website at www.hgsi.com Before we begin, I'd like to point out that we'll be making forward-looking statements based on current intent, belief and expectations. They are subject to certain risks and uncertainties and I encourage everyone to look at our SEC filings for additional detail.

In today's call, I plan to provide an overview of recent accomplishments. Next, Tim Barabe, Senior Vice President and Chief Financial Officer will touch on key aspects of first quarter 2008 financial results.

Finally for the Q&A session, we'll be joined by several other members of our senior management team. The first quarter of 2008 was another period of substantial progress for HGS toward the commercialization of late stage products. It was also a quarter in which HGS moved forward, strategically and opportunistically to strengthen our pipeline. So what you have is a company with three strong Phase 3 products and an emerging pipeline that creates opportunities for future growth. Let's talk about our Phase 3 products first beginning with LymphoStat-B.

Related articles from newspapers, magazines, journals, and more
Human Genome Sciences and Medarex Announce Collaboration.
Press release article from: PR Newswire July 25, 2001 700+ words
...be Used As Novel Drugs for Human Genome Sciences - ROCKVILLE, Md., and...July 25 /PRNewswire/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI...for commercialization by Human Genome Sciences. Under the agreement Human...
Human Genome Sciences Announces Closing of Public Offering.
Press release article from: PR Newswire August 3, 2009 700+ words
...PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. today announced the...to buy any securities of Human Genome Sciences, Inc., nor shall there...800-831-9146. About Human Genome Sciences Human Genome Sciences is...
Human Genome Sciences Announces Pricing of Public Offering of Common Stock.
Press release article from: PR Newswire July 28, 2009 700+ words
...PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. today announced the...to buy any securities of Human Genome Sciences, Inc., nor shall there...800-831-9146. About Human Genome Sciences Human Genome Sciences is...
Human Genome Sciences Announces Proposed Public Offering of Common Stock.
Press release article from: PR Newswire July 27, 2009 700+ words
...July 27 /PRNewswire/ -- Human Genome Sciences, Inc. today announced that...to buy any securities of Human Genome Sciences, Inc., nor shall there...800-831-9146. About Human Genome Sciences Human Genome Sciences is...
Human Genome Sciences Establishes New Subsidiary in Europe.
Press release article from: PR Newswire January 23, 2003 700+ words
...Collaborations in European Countries - Human Genome Sciences, Inc. announced today the creation of Human Genome Sciences Europe GmbH, a new subsidiary...for Bayer AG, has joined Human Genome Sciences as Vice President, Drug...
Human Genome Sciences establishes new subsidiary in Europe.
Press release article from: PR Newswire January 23, 2003 700+ words
...collaborations in European countries Human Genome Sciences, Inc. announced today the creation of Human Genome Sciences Europe GmbH, a new subsidiary...for Bayer AG, has joined Human Genome Sciences as Vice President, Drug...
Human Genome Sciences and Medarex announce antibody collaboration.(Brief...
Newspaper article from: BIOTECH Patent News July 1, 2001 700+ words
Human Genome Sciences, Inc. (Rockville, MD; 301-309-8504) and...fully human antibodies for commercialization by Human Genome Sciences. Under the agreement Human Genome Sciences has an option to exclusively license therapeutic...
Cambridge Antibody Technology and Human Genome Sciences Announce Second Drug...
Press release article from: PR Newswire January 8, 2002 700+ words
...Cambridge Antibody Technology and Human Genome Sciences, Inc. today announce that Human Genome Sciences has exercised an option to enter into...evaluated as an anti-cancer drug by Human Genome Sciences. TRAIL Receptor 1, which was discovered...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA